Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
$6.62
$0.00
$1.68
$7.35
N/AN/A105,587 shsN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$1.14
-1.7%
$1.30
$1.09
$3.55
$83.59M0.9398,278 shs231,575 shs
PPR
Voya Prime Rate Trust
$4.67
$4.63
$4.00
$4.70
N/AN/A406,378 shs548,337 shs
WEL
Integrated Wellness Acquisition
$11.48
$11.38
$10.57
$12.41
$81.85M0.036,513 shs15 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
0.00%0.00%0.00%0.00%0.00%
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
-1.72%-0.87%-8.06%-21.38%-58.99%
PPR
Voya Prime Rate Trust
0.00%0.00%0.00%0.00%0.00%
WEL
Integrated Wellness Acquisition
0.00%+0.17%+0.70%+1.86%+8.51%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
N/AN/AN/AN/AN/AN/AN/AN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
3.4162 of 5 stars
3.50.00.00.03.20.03.1
PPR
Voya Prime Rate Trust
N/AN/AN/AN/AN/AN/AN/AN/A
WEL
Integrated Wellness Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
N/AN/AN/AN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
3.00
Buy$10.00777.19% Upside
PPR
Voya Prime Rate Trust
N/AN/AN/AN/A
WEL
Integrated Wellness Acquisition
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
N/AN/AN/AN/AN/AN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$65.49M1.28$0.13 per share8.50$0.47 per share2.43
PPR
Voya Prime Rate Trust
N/AN/AN/AN/AN/AN/A
WEL
Integrated Wellness Acquisition
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
N/AN/A0.00N/AN/AN/AN/AN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$8.31M$0.0522.801.41N/A12.69%29.73%10.17%N/A
PPR
Voya Prime Rate Trust
N/AN/A0.00N/AN/AN/AN/AN/A
WEL
Integrated Wellness Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A

Latest PLX, WEL, UOG, PPR, and HNR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/14/2024Q4 2023
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
-$0.03-$0.07-$0.04-$0.07$8.15 million$10.49 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
N/AN/AN/AN/AN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
N/AN/AN/AN/AN/A
PPR
Voya Prime Rate Trust
$0.286.00%N/AN/A1 Years
WEL
Integrated Wellness Acquisition
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
N/AN/AN/A
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
N/A
1.54
1.12
PPR
Voya Prime Rate Trust
N/AN/AN/A
WEL
Integrated Wellness Acquisition
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Harvest Natural Resources Inc stock logo
HNR
Harvest Natural Resources
N/AN/AN/ANot Optionable
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
20873.32 million69.67 millionOptionable
PPR
Voya Prime Rate Trust
N/AN/AN/ANot Optionable
WEL
Integrated Wellness Acquisition
N/A7.13 million4.65 millionNot Optionable

PLX, WEL, UOG, PPR, and HNR Headlines

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Harvest Natural Resources logo

Harvest Natural Resources

NYSE:HNR
Harvest Natural Resources, Inc. (Harvest) is in the process of dissolution and winding up. The Company was previously a petroleum exploration and production company. The Company was engaged in acquiring exploration, development and producing properties in geological basins active hydrocarbon systems.
Protalix BioTherapeutics logo

Protalix BioTherapeutics

NYSE:PLX
Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell-expressed recombinant PEGylated Uricase which is in Phase I trial for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate that is in preclinical phase for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. The company was incorporated in 1993 and is headquartered in Karmiel, Israel. Protalix BioTherapeutics, Inc. is a subsidiary of Protalix Ltd.

Voya Prime Rate Trust

NYSE:PPR
Saba Cap Income & Opportunities Fund operates as a diversified, closed-end management investment company. It seeks to provide investors with as high a level of current income as is consistent with the preservation of capital. The company was founded on December 2, 1987 and is headquartered in Scottsdale, AZ.

Integrated Wellness Acquisition

NYSE:WEL
Integrated Wellness Acquisition Corp does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the health, nutrition, fitness, wellness, and beauty sectors. Integrated Wellness Acquisition Corp was incorporated in 2021 and is based in Florida, New York.